H Funatsu, H Noma, T Mimura, S Eguchi, S … - Ophthalmology, 2009 - Elsevier Vitreous fluid samples were obtained during vitreoretinal surgery, and the
levels of vascular endothelial growth factor (VEGF), intercellular adhesion
molecule (ICAM)-1, interleukin (IL)-6, monocyte chemotactic protein ... Cited by 7 - Related articles - All 18 versions
K Örnek, N Örnek - Journal of Ocular Pharmacology and Therapeutics, 2008 - liebertonline.com Introduction D IABETIC MACULAR EDEMA (DME) is still the main cause of visual
loss in patients with diabetic retinopathy. Treat- ment of DME includes macular
laser photocoagulation (MLP), pars plana vitrectomy (PPV), and the ... Cited by 4 - Related articles - All 3 versions
FE Kane, J Burdan, A Cutino, KE Green - Expert Opin. Drug Deliv., 2008 - informahealthcare.com Iluvien ™ (fluocinolone acetonide intravitreal insert, Alimera Sciences,
Inc.), a novel injectable intravitreal insert, is being studied to deliver a
very low dose of a corticosteroid to the retina for up to 3 years as a ... Cited by 3 - Related articles - All 6 versions
- ►prsjournal.com MIIN ROH, SUKHO BYEON, OHW KWON - Retina, 2008 - journals.lww.com Intravitreal bevacizumab (IVB) is a novel treatment modality for several ocular
diseases, including cho- roidal neovascularization,1,2 diabetic retinopathy,3,4
and central retinal vein occlusion.5–7 Although bev- acizumab shows ... Cited by 3 - Related articles - All 3 versions
- ►prsjournal.com DSC LAM, TYY LAI, VYW LEE, CKM CHAN, … - Retina, 2009 - journals.lww.com From the *Department of Ophthalmology and Visual Sciences, the Chinese
University of Hong Kong, Hong Kong; †Hong Kong Eye Hospital, Kowloon, Hong
Kong; and ‡Prince of Wales Hospital, Shatin, New Territories, Hong Kong. Cited by 3 - Related articles - All 5 versions
- ►duanessolution.com PA Keane, SR Sadda - International Ophthalmology Clinics, 2009 - journals.lww.com Diabetes mellitus affects more than 20 million people in the United States and
diabetic retinopathy, a microvascular complication of diabetes, is the leading
cause of blindness among people of working age in this country.1 Globally, ... Cited by 1 - Related articles - All 4 versions
JB Gunther, MM Altaweel - Survey of Ophthalmology, 2009 - Elsevier The use of intravitreal bevacizumab (Avastin) has greatly expanded since its
introduction into ophthalmic care 3 years ago. A PubMed search on 1 August 2008
revealed 51 ocular disease processes that have been treated with ... Cited by 2 - Related articles - All 23 versions
SB Oh, JW Moon, HC Kim - J Korean Ophthalmol Soc, 2009 - synapse.koreamed.org For this study, the medical records of patients with diabetic macular edema, who
received intravitreal triamcinolone injection (IVTA) or intravitreal bevacizumab
injection (IVB), were reviewed. Best corrected visual acuity (BCVA), ... Related articles - Cached
RN Khurana, DV Do, QD Nguyen - International Ophthalmology Clinics, 2009 - journals.lww.com Diabetic retinopathy is the leading cause of blindness in people of working
age.1 Diabetic macular edema (DME) is the most common cause of moderate vision
loss among this population.2,3 The Early Treatment Diabetic Retinopathy ... Related articles - All 2 versions
AJ Barkmeier, L Akduman - Ocular Immunology and Inflammation, 2009 - informahealthcare.com Vascular endothelial growth factor (VEGF) and its receptors play an important
role in many pathologic ocular processes. VEGF binding initiates an
intracellular cascade that leads to proliferation and migration of vascular ... Related articles - All 6 versions
